Header Logo

Connection

Alan Go to Aged

This is a "connection" page, showing publications Alan Go has written about Aged.
Connection Strength

7.921
  1. Utility of Risk Scores for Predicting Stroke and Intracranial Bleeding Across Levels of Kidney Function in Two Large Community-Based Cohorts of Older Adults With Atrial Fibrillation. Am J Kidney Dis. 2026 Sep; 88(3):341-355.
    View in: PubMed
    Score: 0.114
  2. Proactive Engagement of Patients With Advanced Chronic Kidney Disease to Reduce Clinical Complications: The Kaiser Permanente Northern California Experience. Perm J. 2026 06 15; 30(2):20-29.
    View in: PubMed
    Score: 0.113
  3. Enhancing risk stratification for incident systolic heart failure through machine learning and natural language processing. Am Heart J. 2026 Feb; 292:107280.
    View in: PubMed
    Score: 0.109
  4. Incidence of Heart Failure in Asian American, Native Hawaiian, and Other Pacific Islander Populations. J Am Coll Cardiol. 2025 Sep 09; 86(10):725-734.
    View in: PubMed
    Score: 0.108
  5. CKD stage-specific utility of two equations for predicting 1-year risk of ESKD. PLoS One. 2023; 18(11):e0293293.
    View in: PubMed
    Score: 0.095
  6. Approach to Multimorbidity Burden Classification and Outcomes in Older Adults With Heart Failure. Med Care. 2023 05 01; 61(5):268-278.
    View in: PubMed
    Score: 0.091
  7. Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community-Based Population. J Am Heart Assoc. 2023 03 21; 12(6):e028290.
    View in: PubMed
    Score: 0.091
  8. Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Stroke. 2023 Mar; 54(3):e75-e85.
    View in: PubMed
    Score: 0.091
  9. Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding. J Thromb Thrombolysis. 2022 Oct; 54(3):470-479.
    View in: PubMed
    Score: 0.088
  10. Analysis of Worsening Heart Failure Events in an Integrated Health Care System. J Am Coll Cardiol. 2022 Jul 12; 80(2):111-122.
    View in: PubMed
    Score: 0.087
  11. Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. BMJ Open. 2022 01 31; 12(1):e048755.
    View in: PubMed
    Score: 0.084
  12. A Natural Language Processing-Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System. JAMA Netw Open. 2021 11 01; 4(11):e2135152.
    View in: PubMed
    Score: 0.083
  13. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377.
    View in: PubMed
    Score: 0.083
  14. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
    View in: PubMed
    Score: 0.079
  15. Implication of Trends in Timing of Dialysis Initiation for Incidence of End-stage Kidney Disease. JAMA Intern Med. 2020 12 01; 180(12):1647-1654.
    View in: PubMed
    Score: 0.078
  16. Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020 09 25; 75(10):1981-1988.
    View in: PubMed
    Score: 0.077
  17. The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study: A Pragmatic Randomized Trial. Circ Cardiovasc Qual Outcomes. 2020 10; 13(10):e006553.
    View in: PubMed
    Score: 0.077
  18. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations. Circ Cardiovasc Qual Outcomes. 2020 09; 13(9):e006415.
    View in: PubMed
    Score: 0.076
  19. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction. J Am Heart Assoc. 2020 03 17; 9(6):e014415.
    View in: PubMed
    Score: 0.074
  20. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI. Clin J Am Soc Nephrol. 2020 01 07; 15(1):26-34.
    View in: PubMed
    Score: 0.073
  21. Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications. Am J Cardiol. 2020 02 15; 125(4):553-561.
    View in: PubMed
    Score: 0.072
  22. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.072
  23. Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The CVRN VTE Study. Am J Med. 2019 12; 132(12):1450-1457.e1.
    View in: PubMed
    Score: 0.070
  24. Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department. West J Emerg Med. 2018 Mar; 19(2):346-360.
    View in: PubMed
    Score: 0.064
  25. Short-Term Outcomes and Factors Associated With Adverse Events Among Adults Discharged From the Emergency Department After Treatment for Acute Heart Failure. Circ Heart Fail. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.063
  26. Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study. Ann Intern Med. 2017 Dec 19; 167(12):845-854.
    View in: PubMed
    Score: 0.063
  27. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease. J Am Geriatr Soc. 2017 Dec; 65(12):2610-2618.
    View in: PubMed
    Score: 0.062
  28. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.062
  29. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
    View in: PubMed
    Score: 0.058
  30. Community-Based Trends in Acute Myocardial Infarction From 2008 to 2014. J Am Coll Cardiol. 2016 08 09; 68(6):666-668.
    View in: PubMed
    Score: 0.058
  31. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
    View in: PubMed
    Score: 0.057
  32. Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization. Med Care. 2016 Apr; 54(4):365-72.
    View in: PubMed
    Score: 0.056
  33. High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart. 2016 08 01; 102(15):1177-82.
    View in: PubMed
    Score: 0.056
  34. Incidence and timing of potentially high-risk arrhythmias detected through long term continuous ambulatory electrocardiographic monitoring. BMC Cardiovasc Disord. 2016 Feb 17; 16:35.
    View in: PubMed
    Score: 0.056
  35. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens. 2016 Feb; 34(2):244-52.
    View in: PubMed
    Score: 0.056
  36. Elevated BP after AKI. J Am Soc Nephrol. 2016 Mar; 27(3):914-23.
    View in: PubMed
    Score: 0.053
  37. Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study. JAMA Intern Med. 2015 Jun; 175(6):1060-2.
    View in: PubMed
    Score: 0.053
  38. Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2015 Apr 14; 65(14):1411-20.
    View in: PubMed
    Score: 0.053
  39. Age, sex, and racial influences on the Beckman Coulter AccuTnI+3 99th percentile. Clin Chim Acta. 2015 Apr 15; 444:149-53.
    View in: PubMed
    Score: 0.052
  40. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58.
    View in: PubMed
    Score: 0.051
  41. Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention. Am Heart J. 2015 Jan; 169(1):149-54.
    View in: PubMed
    Score: 0.051
  42. Incident atrial fibrillation and risk of death in adults with chronic kidney disease. J Am Heart Assoc. 2014 Oct 20; 3(5):e001303.
    View in: PubMed
    Score: 0.051
  43. Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. J Am Coll Cardiol. 2014 Sep 09; 64(10):985-94.
    View in: PubMed
    Score: 0.051
  44. The association of gender to cardiovascular outcomes after coronary artery revascularization in patients with end-stage renal disease. Clin Cardiol. 2014 Sep; 37(9):546-51.
    View in: PubMed
    Score: 0.050
  45. Hospital-level variation in use of cardiovascular testing for adults with incident heart failure: findings from the cardiovascular research network heart failure study. JACC Cardiovasc Imaging. 2014 Jul; 7(7):690-700.
    View in: PubMed
    Score: 0.050
  46. CKD and the risk of incident cancer. J Am Soc Nephrol. 2014 Oct; 25(10):2327-34.
    View in: PubMed
    Score: 0.050
  47. Temporal trends in mortality after coronary artery revascularization in patients with end-stage renal disease. Perm J. 2014; 18(3):11-6.
    View in: PubMed
    Score: 0.048
  48. Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries. J Am Coll Cardiol. 2014 Jan 7-14; 63(1):33-9.
    View in: PubMed
    Score: 0.047
  49. Effectiveness and safety of spironolactone for systolic heart failure. Am J Cardiol. 2013 Nov 01; 112(9):1427-32.
    View in: PubMed
    Score: 0.047
  50. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes. 2013 Sep 01; 6(5):525-33.
    View in: PubMed
    Score: 0.047
  51. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013 Aug 21; 310(7):699-705.
    View in: PubMed
    Score: 0.047
  52. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013 Jun 21; 2(3):e000250.
    View in: PubMed
    Score: 0.046
  53. Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail. 2013 Jul; 6(4):635-46.
    View in: PubMed
    Score: 0.046
  54. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med. 2013 May 21; 158(10):727-34.
    View in: PubMed
    Score: 0.046
  55. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 01; 6(3):333-42.
    View in: PubMed
    Score: 0.046
  56. Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Am Heart J. 2013 May; 165(5):800-8, 808.e1-2.
    View in: PubMed
    Score: 0.046
  57. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013 May; 126(5):393-400.
    View in: PubMed
    Score: 0.046
  58. Effectiveness of ß-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease. J Card Fail. 2013 Mar; 19(3):176-82.
    View in: PubMed
    Score: 0.045
  59. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013 Feb 05; 127(5):569-74.
    View in: PubMed
    Score: 0.045
  60. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol. 2013 Jan 22; 61(3):295-301.
    View in: PubMed
    Score: 0.045
  61. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke. 2012 Oct; 43(10):2788-90.
    View in: PubMed
    Score: 0.044
  62. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol. 2011 Oct 04; 58(15):1600-7.
    View in: PubMed
    Score: 0.041
  63. Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol. 2011 Sep 14; 12:44.
    View in: PubMed
    Score: 0.041
  64. Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med. 2011 Jun 24; 9:78.
    View in: PubMed
    Score: 0.040
  65. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.040
  66. Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Feb; 6(2):248-56.
    View in: PubMed
    Score: 0.038
  67. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010 Aug 27; 11:22.
    View in: PubMed
    Score: 0.038
  68. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010 Jun 10; 362(23):2155-65.
    View in: PubMed
    Score: 0.038
  69. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med. 2010 May 10; 170(9):759-64.
    View in: PubMed
    Score: 0.037
  70. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009 Sep 01; 151(5):297-305.
    View in: PubMed
    Score: 0.036
  71. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2(4):297-304.
    View in: PubMed
    Score: 0.035
  72. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009 May; 4(5):891-8.
    View in: PubMed
    Score: 0.035
  73. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009 Mar 17; 119(10):1363-9.
    View in: PubMed
    Score: 0.034
  74. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009 Feb 23; 169(4):342-50.
    View in: PubMed
    Score: 0.034
  75. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med. 2008 Dec 08; 168(22):2415-21.
    View in: PubMed
    Score: 0.034
  76. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke. 2008 Jun; 39(6):1901-10.
    View in: PubMed
    Score: 0.032
  77. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J. 2007 Dec; 154(6):1035-42.
    View in: PubMed
    Score: 0.031
  78. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
    View in: PubMed
    Score: 0.031
  79. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.029
  80. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006 Dec 15; 164(12):1150-9.
    View in: PubMed
    Score: 0.029
  81. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006 Oct; 17(10):2892-9.
    View in: PubMed
    Score: 0.029
  82. Epidemiology, clinical characteristics, and outcomes for heart failure with improved ejection fraction by chronological age. ESC Heart Fail. 2026 Jul 04; 13(4).
    View in: PubMed
    Score: 0.029
  83. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23.
    View in: PubMed
    Score: 0.028
  84. Real-world incidence of cancer therapy-related cardiac dysfunction in a large, diverse, and contemporary cohort. ESC Heart Fail. 2026 05 05; 13(3).
    View in: PubMed
    Score: 0.028
  85. Independent association between acute kidney injury and kidney function trajectory. Kidney Int. 2026 Jul; 110(1):206-213.
    View in: PubMed
    Score: 0.028
  86. Attaining LDL-cholesterol target post major coronary event: Care gap, associated factors and clinical outcomes. Am Heart J. 2026 Jul; 297:107430.
    View in: PubMed
    Score: 0.028
  87. Association of Guideline-Concordant Echocardiographic Surveillance With Mortality and Aortic Valve Replacement in US Adults With Aortic Stenosis. Circ Popul Health Outcomes. 2026 Apr; 19(4):e012822.
    View in: PubMed
    Score: 0.028
  88. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006 Feb 21; 144(4):229-38.
    View in: PubMed
    Score: 0.028
  89. Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney disease. ESC Heart Fail. 2026 Feb 03; 13(1).
    View in: PubMed
    Score: 0.028
  90. Transcriptome-wide association study of cardiovascular outcomes in chronic kidney disease: The chronic renal insufficiency cohort. HGG Adv. 2026 Apr 09; 7(2):100562.
    View in: PubMed
    Score: 0.028
  91. Optimizing Proteinuria Evaluation and Management after Acute Kidney Injury: Insights from the Chronic Renal Insufficiency Cohort Study. Kidney360. 2026 Mar 01; 7(3):527-534.
    View in: PubMed
    Score: 0.027
  92. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005 Nov; 68(5):2310-6.
    View in: PubMed
    Score: 0.027
  93. Worsening heart failure events in adults with mild-to-moderate chronic kidney disease. Am Heart J. 2026 Feb; 292:107290.
    View in: PubMed
    Score: 0.027
  94. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005 Sep 20; 112(12):1687-91.
    View in: PubMed
    Score: 0.027
  95. Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction. J Am Coll Cardiol. 2025 Aug 05; 86(5):338-350.
    View in: PubMed
    Score: 0.027
  96. Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease. J Am Heart Assoc. 2025 Jul 15; 14(14):e039868.
    View in: PubMed
    Score: 0.027
  97. Electronically delivered, cardiovascular-focused messaging to improve influenza vaccination: Rationale, design, and baseline characteristics of the Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement (KP-VACCINATE) Megatrial. Am Heart J. 2025 Dec; 290:129-139.
    View in: PubMed
    Score: 0.027
  98. Association of Rate-Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation. J Am Heart Assoc. 2025 Jun 17; 14(12):e038511.
    View in: PubMed
    Score: 0.027
  99. Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKI. BMC Nephrol. 2025 Jun 02; 26(1):271.
    View in: PubMed
    Score: 0.027
  100. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005 Mar-Apr; 14(2):56-61.
    View in: PubMed
    Score: 0.026
  101. Decision Support Intervention and Anticoagulation for Emergency Department Atrial Fibrillation: The O'CAF? Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Netw Open. 2024 Nov 04; 7(11):e2443097.
    View in: PubMed
    Score: 0.026
  102. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 09 23; 351(13):1296-305.
    View in: PubMed
    Score: 0.025
  103. Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction. Am Heart J. 2024 Dec; 278:117-126.
    View in: PubMed
    Score: 0.025
  104. The importance of anticoagulation management services. Manag Care. 2004 Sep; 13(9 Suppl):20-5.
    View in: PubMed
    Score: 0.025
  105. Effect of Screening for Undiagnosed?Atrial Fibrillation on?Stroke?Prevention. J Am Coll Cardiol. 2024 Nov 19; 84(21):2073-2084.
    View in: PubMed
    Score: 0.025
  106. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003 Nov 26; 290(20):2685-92.
    View in: PubMed
    Score: 0.024
  107. The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney disease. Sci Rep. 2023 05 31; 13(1):8863.
    View in: PubMed
    Score: 0.023
  108. Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Thromb Thrombolysis. 2003 Feb; 15(1):41-6.
    View in: PubMed
    Score: 0.023
  109. Association of Thoracic Aortic Aneurysm Size With Long-term Patient Outcomes: The KP-TAA Study. JAMA Cardiol. 2022 11 01; 7(11):1160-1169.
    View in: PubMed
    Score: 0.022
  110. ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor. Am Heart J. 2022 07; 249:76-85.
    View in: PubMed
    Score: 0.021
  111. Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort. J Am Heart Assoc. 2022 Apr 05; 11(7):e022891.
    View in: PubMed
    Score: 0.021
  112. Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic. Clin Cardiol. 2022 Feb; 45(2):180-188.
    View in: PubMed
    Score: 0.021
  113. Race, Genetic Ancestry, and Estimating Kidney Function in CKD. N Engl J Med. 2021 11 04; 385(19):1750-1760.
    View in: PubMed
    Score: 0.021
  114. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 09; 285(18):2370-5.
    View in: PubMed
    Score: 0.020
  115. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study. Am J Kidney Dis. 2021 08; 78(2):200-209.e1.
    View in: PubMed
    Score: 0.020
  116. Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med. 2001 Feb; 17(1):131-47.
    View in: PubMed
    Score: 0.020
  117. Biomarkers of inflammation and repair in kidney disease progression. J Clin Invest. 2021 02 01; 131(3).
    View in: PubMed
    Score: 0.020
  118. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 08; 78(2):226-235.e1.
    View in: PubMed
    Score: 0.020
  119. Mobile Health (mHealth) Technology: Assessment of Availability, Acceptability, and Use in CKD. Am J Kidney Dis. 2021 06; 77(6):941-950.e1.
    View in: PubMed
    Score: 0.019
  120. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 06; 77(6):907-919.
    View in: PubMed
    Score: 0.019
  121. Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):263-272.
    View in: PubMed
    Score: 0.019
  122. Neighborhood socioeconomic status and risk of hospitalization in patients with chronic kidney disease: A chronic renal insufficiency cohort study. Medicine (Baltimore). 2020 Jul 10; 99(28):e21028.
    View in: PubMed
    Score: 0.019
  123. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation. 2000 Jul 04; 102(1):11-3.
    View in: PubMed
    Score: 0.019
  124. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure. J Am Heart Assoc. 2020 07 07; 9(13):e014385.
    View in: PubMed
    Score: 0.019
  125. Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2021 02; 105(2):246-252.
    View in: PubMed
    Score: 0.019
  126. Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2020 08; 226:85-93.
    View in: PubMed
    Score: 0.019
  127. Association Between Early Recovery of Kidney Function After Acute Kidney Injury and Long-term Clinical Outcomes. JAMA Netw Open. 2020 04 01; 3(4):e202682.
    View in: PubMed
    Score: 0.019
  128. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.
    View in: PubMed
    Score: 0.019
  129. Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. JAMA Intern Med. 2020 03 01; 180(3):402-410.
    View in: PubMed
    Score: 0.018
  130. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999 Dec 21; 131(12):927-34.
    View in: PubMed
    Score: 0.018
  131. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019 12; 12(12):e007612.
    View in: PubMed
    Score: 0.018
  132. Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. JAMA Cardiol. 2019 12 01; 4(12):1280-1286.
    View in: PubMed
    Score: 0.018
  133. Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e006212.
    View in: PubMed
    Score: 0.018
  134. Serum Calcification Propensity and Clinical Events in CKD. Clin J Am Soc Nephrol. 2019 11 07; 14(11):1562-1571.
    View in: PubMed
    Score: 0.018
  135. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc. 2019 11 05; 8(21):e012336.
    View in: PubMed
    Score: 0.018
  136. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. Am J Kidney Dis. 2019 12; 74(6):771-781.
    View in: PubMed
    Score: 0.018
  137. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
    View in: PubMed
    Score: 0.018
  138. Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts. J Am Soc Nephrol. 2019 07; 30(7):1271-1281.
    View in: PubMed
    Score: 0.018
  139. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease. J Am Coll Cardiol. 2019 06 04; 73(21):2691-2700.
    View in: PubMed
    Score: 0.018
  140. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90.
    View in: PubMed
    Score: 0.017
  141. Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. J Thromb Thrombolysis. 2018 Nov; 46(4):435-439.
    View in: PubMed
    Score: 0.017
  142. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
    View in: PubMed
    Score: 0.016
  143. Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury. Kidney Int. 2018 04; 93(4):968-976.
    View in: PubMed
    Score: 0.016
  144. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
    View in: PubMed
    Score: 0.016
  145. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation). Circ Arrhythm Electrophysiol. 2017 Nov; 10(11).
    View in: PubMed
    Score: 0.016
  146. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017 Sep 12; 70(11):1325-1335.
    View in: PubMed
    Score: 0.016
  147. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1795-1803.
    View in: PubMed
    Score: 0.015
  148. Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort. Am J Hypertens. 2017 Aug 01; 30(8):822-829.
    View in: PubMed
    Score: 0.015
  149. Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2017 08; 70(2):435-443.
    View in: PubMed
    Score: 0.015
  150. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. Eur Heart J Qual Care Clin Outcomes. 2017 07 01; 3(3):192-197.
    View in: PubMed
    Score: 0.015
  151. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017 Sep; 40(9):746-751.
    View in: PubMed
    Score: 0.015
  152. Health Literacy and Awareness of Atrial Fibrillation. J Am Heart Assoc. 2017 Apr 11; 6(4).
    View in: PubMed
    Score: 0.015
  153. Inflammation and Arterial Stiffness in Chronic Kidney Disease: Findings From the CRIC Study. Am J Hypertens. 2017 Apr 01; 30(4):400-408.
    View in: PubMed
    Score: 0.015
  154. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):761-771.
    View in: PubMed
    Score: 0.015
  155. Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 2017 04; 91(4):948-953.
    View in: PubMed
    Score: 0.015
  156. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke. J Am Geriatr Soc. 2017 Feb; 65(2):241-248.
    View in: PubMed
    Score: 0.015
  157. Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. JAMA. 2016 Nov 15; 316(19):1971-1972.
    View in: PubMed
    Score: 0.015
  158. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study. J Am Geriatr Soc. 2017 01; 65(1):35-41.
    View in: PubMed
    Score: 0.015
  159. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol. 2017 01 06; 12(1):60-68.
    View in: PubMed
    Score: 0.015
  160. Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN). Am J Med. 2017 Mar; 130(3):317-327.
    View in: PubMed
    Score: 0.015
  161. Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling. Circulation. 2016 10 11; 134(15):1122-1124.
    View in: PubMed
    Score: 0.015
  162. Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Kidney Int. 2016 12; 90(6):1348-1356.
    View in: PubMed
    Score: 0.015
  163. Research Needs to Improve Hypertension Treatment and Control in African Americans. Hypertension. 2016 11; 68(5):1066-1072.
    View in: PubMed
    Score: 0.015
  164. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol. 2016 Aug 01; 1(5):548-56.
    View in: PubMed
    Score: 0.014
  165. Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals. JAMA Cardiol. 2016 08 01; 1(5):594-9.
    View in: PubMed
    Score: 0.014
  166. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Heart Assoc. 2016 07 22; 5(7).
    View in: PubMed
    Score: 0.014
  167. Inflammation and Progression of CKD: The CRIC Study. Clin J Am Soc Nephrol. 2016 09 07; 11(9):1546-56.
    View in: PubMed
    Score: 0.014
  168. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? Am J Cardiol. 2016 09 01; 118(5):697-9.
    View in: PubMed
    Score: 0.014
  169. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol. 2016 06; 9(6).
    View in: PubMed
    Score: 0.014
  170. Multimorbidity is strongly associated with long-term but not short-term mortality after cardiac valve replacement. Int J Cardiol. 2016 Jul 15; 215:417-21.
    View in: PubMed
    Score: 0.014
  171. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clin J Am Soc Nephrol. 2016 07 07; 11(7):1189-96.
    View in: PubMed
    Score: 0.014
  172. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016 10; 31(10):1662-9.
    View in: PubMed
    Score: 0.014
  173. Cognitive Impairment and Progression of CKD. Am J Kidney Dis. 2016 Jul; 68(1):77-83.
    View in: PubMed
    Score: 0.014
  174. Association of Age to Mortality and Repeat Revascularization in End-Stage Renal Disease Patients: Implications for Clinicians and Future Health Policies. Perm J. 2016; 20(2):4-9.
    View in: PubMed
    Score: 0.014
  175. Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One. 2016; 11(2):e0148189.
    View in: PubMed
    Score: 0.014
  176. Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol. 2016 Jan 28; 17:13.
    View in: PubMed
    Score: 0.014
  177. Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study. J Am Coll Cardiol. 2016 Jan 26; 67(3):239-47.
    View in: PubMed
    Score: 0.014
  178. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Am J Med. 2016 06; 129(6):592-599.e1.
    View in: PubMed
    Score: 0.014
  179. Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Clin Cardiol. 2016 Feb; 39(2):119-25.
    View in: PubMed
    Score: 0.014
  180. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J. 2016 Apr; 174:29-36.
    View in: PubMed
    Score: 0.014
  181. Gastrointestinal symptoms, inflammation and hypoalbuminemia in chronic kidney disease patients: a cross-sectional study. BMC Nephrol. 2015 Dec 11; 16:211.
    View in: PubMed
    Score: 0.014
  182. Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism. Thromb Res. 2016 Jan; 137:97-102.
    View in: PubMed
    Score: 0.014
  183. Anticoagulation in atrial fibrillation: impact of mental illness. Am J Manag Care. 2015 Nov 01; 21(11):e609-17.
    View in: PubMed
    Score: 0.014
  184. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. Thromb Res. 2015 Dec; 136(6):1160-4.
    View in: PubMed
    Score: 0.014
  185. The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet. 2015 Oct; 11(10):e1005378.
    View in: PubMed
    Score: 0.014
  186. Prevalence and Correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1757-66.
    View in: PubMed
    Score: 0.014
  187. Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-Course. Circ Cardiovasc Genet. 2015 Dec; 8(6):803-11.
    View in: PubMed
    Score: 0.014
  188. A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant. 2015 Dec; 50(12):1519-25.
    View in: PubMed
    Score: 0.014
  189. The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease. Circulation. 2015 Nov 24; 132(21):1999-2011.
    View in: PubMed
    Score: 0.014
  190. Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study. Am J Med. 2015 Nov; 128(11):1252.e1-1252.e11.
    View in: PubMed
    Score: 0.013
  191. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8.
    View in: PubMed
    Score: 0.013
  192. Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):393-402.
    View in: PubMed
    Score: 0.013
  193. Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
    View in: PubMed
    Score: 0.013
  194. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study. Circ Heart Fail. 2015 Jul; 8(4):702-8.
    View in: PubMed
    Score: 0.013
  195. Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization. Am Heart J. 2015 Aug; 170(2):400-8.
    View in: PubMed
    Score: 0.013
  196. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2015 Sep; 30(9):1534-41.
    View in: PubMed
    Score: 0.013
  197. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Am Heart J. 2015 Jul; 170(1):141-8, 148.e1.
    View in: PubMed
    Score: 0.013
  198. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Aug; 66(2):266-73.
    View in: PubMed
    Score: 0.013
  199. The complex relationship of race to outcomes in heart failure with preserved ejection fraction. Am J Med. 2015 Jun; 128(6):591-600.
    View in: PubMed
    Score: 0.013
  200. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014; 40(5):399-407.
    View in: PubMed
    Score: 0.013
  201. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). Am J Cardiol. 2015 Jan 01; 115(1):40-6.
    View in: PubMed
    Score: 0.013
  202. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Feb; 65(2):267-74.
    View in: PubMed
    Score: 0.013
  203. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension. 2015 Jan; 65(1):93-100.
    View in: PubMed
    Score: 0.013
  204. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2015 Apr; 26(4):946-56.
    View in: PubMed
    Score: 0.013
  205. Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2014 Sep; 62(9):1623-9.
    View in: PubMed
    Score: 0.013
  206. Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study. Circ Heart Fail. 2014 Sep; 7(5):709-16.
    View in: PubMed
    Score: 0.013
  207. ß-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol. 2014 Jul 22; 64(3):247-52.
    View in: PubMed
    Score: 0.013
  208. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. Am J Cardiol. 2014 Aug 15; 114(4):583-6.
    View in: PubMed
    Score: 0.012
  209. Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry. Am Heart J. 2014 Aug; 168(2):160-7.
    View in: PubMed
    Score: 0.012
  210. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014 Jun 03; 63(21):2249-57.
    View in: PubMed
    Score: 0.012
  211. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circulation. 2014 May 20; 129(20):2005-12.
    View in: PubMed
    Score: 0.012
  212. Population trends from 2000-2011 in nuclear myocardial perfusion imaging use. JAMA. 2014 Mar 26; 311(12):1248-9.
    View in: PubMed
    Score: 0.012
  213. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2.
    View in: PubMed
    Score: 0.012
  214. Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology. 2014 Mar 25; 82(12):1033-7.
    View in: PubMed
    Score: 0.012
  215. DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrol Dial Transplant. 2014 Apr; 29(4):864-72.
    View in: PubMed
    Score: 0.012
  216. Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study. Eur Heart J. 2014 Aug 14; 35(31):2115-22.
    View in: PubMed
    Score: 0.012
  217. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2014 Feb; 63(2):236-43.
    View in: PubMed
    Score: 0.012
  218. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014 Feb; 25(2):349-60.
    View in: PubMed
    Score: 0.012
  219. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
    View in: PubMed
    Score: 0.012
  220. Associations between use of the hospitalist model and quality of care and outcomes of older patients hospitalized for heart failure. JACC Heart Fail. 2013 Oct; 1(5):445-53.
    View in: PubMed
    Score: 0.012
  221. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Circulation. 2013 Aug 13; 128(7):721-8.
    View in: PubMed
    Score: 0.012
  222. Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA. 2013 Jul 10; 310(2):155-62.
    View in: PubMed
    Score: 0.012
  223. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):461-9.
    View in: PubMed
    Score: 0.012
  224. Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort). J Am Coll Cardiol. 2013 Aug 27; 62(9):789-98.
    View in: PubMed
    Score: 0.012
  225. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA. 2013 May 15; 309(19):2025-34.
    View in: PubMed
    Score: 0.012
  226. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
    View in: PubMed
    Score: 0.011
  227. Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol. 2013 May 01; 111(9):1324-9.
    View in: PubMed
    Score: 0.011
  228. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Feb 01; 2(1):e005694.
    View in: PubMed
    Score: 0.011
  229. Association of cardiac troponin T with left ventricular structure and function in CKD. Am J Kidney Dis. 2013 May; 61(5):701-9.
    View in: PubMed
    Score: 0.011
  230. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc. 2013 Jan; 61(1):26-33.
    View in: PubMed
    Score: 0.011
  231. Validation of the Kidney Disease Quality of Life Short Form 36 (KDQOL-36) US Spanish and English versions in a cohort of Hispanics with chronic kidney disease. Ethn Dis. 2013; 23(2):202-9.
    View in: PubMed
    Score: 0.011
  232. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013 Jan 15; 127(2):224-32.
    View in: PubMed
    Score: 0.011
  233. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013 Jan; 45(1):25-33.
    View in: PubMed
    Score: 0.011
  234. Retinopathy and cognitive impairment in adults with CKD. Am J Kidney Dis. 2013 Feb; 61(2):219-27.
    View in: PubMed
    Score: 0.011
  235. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol. 2013 Feb 01; 111(3):432-8.
    View in: PubMed
    Score: 0.011
  236. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):e78-85.
    View in: PubMed
    Score: 0.011
  237. Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol. 2012 Dec 15; 110(12):1735-41.
    View in: PubMed
    Score: 0.011
  238. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012 Oct; 23(10):1725-34.
    View in: PubMed
    Score: 0.011
  239. Recruitment of Hispanics into an observational study of chronic kidney disease: the Hispanic Chronic Renal Insufficiency Cohort Study experience. Contemp Clin Trials. 2012 Nov; 33(6):1238-44.
    View in: PubMed
    Score: 0.011
  240. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke. 2012 Jul; 43(7):1795-9.
    View in: PubMed
    Score: 0.011
  241. Pharmacotherapy in Medicare beneficiaries with atrial fibrillation. Heart Rhythm. 2012 Sep; 9(9):1403-8.
    View in: PubMed
    Score: 0.011
  242. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012 Jan 10; 59(2):143-9.
    View in: PubMed
    Score: 0.011
  243. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):188-97.
    View in: PubMed
    Score: 0.010
  244. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
    View in: PubMed
    Score: 0.010
  245. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011 Nov; 121(11):4393-408.
    View in: PubMed
    Score: 0.010
  246. Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2121-31.
    View in: PubMed
    Score: 0.010
  247. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011 Jul 19; 58(4):395-401.
    View in: PubMed
    Score: 0.010
  248. Racial variation in lipoprotein-associated phospholipase A2 in older adults. BMC Cardiovasc Disord. 2011 Jun 29; 11:38.
    View in: PubMed
    Score: 0.010
  249. CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis. 2011 Aug; 58(2):214-27.
    View in: PubMed
    Score: 0.010
  250. Physical activity in older subjects is associated with increased coronary vasodilation: the ADVANCE study. JACC Cardiovasc Imaging. 2011 Jun; 4(6):622-9.
    View in: PubMed
    Score: 0.010
  251. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31.
    View in: PubMed
    Score: 0.010
  252. Ankle brachial index screening in asymptomatic older adults. Am Heart J. 2011 May; 161(5):979-85.
    View in: PubMed
    Score: 0.010
  253. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol. 2011; 33(6):477-84.
    View in: PubMed
    Score: 0.010
  254. Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure. J Card Fail. 2011 Jan; 17(1):17-23.
    View in: PubMed
    Score: 0.010
  255. Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J Cardiovasc Magn Reson. 2010 Dec 30; 12:75.
    View in: PubMed
    Score: 0.010
  256. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 01; 123(4):e18-e209.
    View in: PubMed
    Score: 0.010
  257. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011 Jan 04; 154(1):1-11.
    View in: PubMed
    Score: 0.010
  258. Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):624-31.
    View in: PubMed
    Score: 0.010
  259. Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation. 2010 Oct 12; 122(15):1478-87.
    View in: PubMed
    Score: 0.010
  260. Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension. 2010 Sep; 56(3):518-24.
    View in: PubMed
    Score: 0.009
  261. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010 Jun; 159(6):1102-7.
    View in: PubMed
    Score: 0.009
  262. Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). Circ Cardiovasc Interv. 2010 Jun 01; 3(3):230-5.
    View in: PubMed
    Score: 0.009
  263. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):303-8.
    View in: PubMed
    Score: 0.009
  264. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010 Feb; 58(2):338-45.
    View in: PubMed
    Score: 0.009
  265. Ethnic differences in anemia among patients with diabetes mellitus: the Diabetes Study of Northern California (DISTANCE). Am J Hematol. 2010 Jan; 85(1):57-61.
    View in: PubMed
    Score: 0.009
  266. Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults. J Phys Act Health. 2010 Jan; 7(1):87-94.
    View in: PubMed
    Score: 0.009
  267. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010 Mar; 23(3):282-9.
    View in: PubMed
    Score: 0.009
  268. Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Clin Chem. 2010 Jan; 56(1):111-20.
    View in: PubMed
    Score: 0.009
  269. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010 Feb; 68(2):243-53.
    View in: PubMed
    Score: 0.009
  270. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009 Oct; 76(8):893-9.
    View in: PubMed
    Score: 0.009
  271. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009 Aug; 4(8):1302-11.
    View in: PubMed
    Score: 0.009
  272. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
    View in: PubMed
    Score: 0.009
  273. Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J. 2009 May; 157(5):939-45.
    View in: PubMed
    Score: 0.009
  274. Incidental pulmonary nodules on cardiac computed tomography: prognosis and use. Am J Med. 2008 Nov; 121(11):989-96.
    View in: PubMed
    Score: 0.008
  275. Chronic conditions and mortality among the oldest old. Am J Public Health. 2008 Jul; 98(7):1209-14.
    View in: PubMed
    Score: 0.008
  276. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet. 2008 Aug 01; 17(15):2320-8.
    View in: PubMed
    Score: 0.008
  277. Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. Arch Intern Med. 2008 Apr 14; 168(7):756-61.
    View in: PubMed
    Score: 0.008
  278. Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet. 2008 May; 123(4):399-408.
    View in: PubMed
    Score: 0.008
  279. Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification. JACC Cardiovasc Imaging. 2008 Mar; 1(2):167-73.
    View in: PubMed
    Score: 0.008
  280. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008 Feb 26; 51(8):810-5.
    View in: PubMed
    Score: 0.008
  281. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Am Heart J. 2007 Dec; 154(6):1043-51.
    View in: PubMed
    Score: 0.008
  282. Patient sex and quality of ED care for patients with myocardial infarction. Am J Emerg Med. 2007 Nov; 25(9):996-1003.
    View in: PubMed
    Score: 0.008
  283. A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Atherosclerosis. 2008 May; 198(1):136-44.
    View in: PubMed
    Score: 0.008
  284. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007 Oct; 50(4):552-8.
    View in: PubMed
    Score: 0.008
  285. Correlation between pulse wave velocity and other measures of arterial stiffness in chronic kidney disease. Clin Nephrol. 2007 Sep; 68(3):133-43.
    View in: PubMed
    Score: 0.008
  286. Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics. 2007 Nov 14; 31(3):402-9.
    View in: PubMed
    Score: 0.008
  287. Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years. Am J Cardiol. 2007 Sep 15; 100(6):981-5.
    View in: PubMed
    Score: 0.008
  288. Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf. 2007 Jun; 16(6):620-6.
    View in: PubMed
    Score: 0.008
  289. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007 Aug; 120(8):700-5.
    View in: PubMed
    Score: 0.008
  290. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Ann Epidemiol. 2007 Sep; 17(9):669-78.
    View in: PubMed
    Score: 0.008
  291. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab. 2007 Feb; 92(2):729-32.
    View in: PubMed
    Score: 0.007
  292. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc. 2006 Aug; 54(8):1231-6.
    View in: PubMed
    Score: 0.007
  293. Validation of a new brief physical activity survey among men and women aged 60-69 years. Am J Epidemiol. 2006 Sep 15; 164(6):598-606.
    View in: PubMed
    Score: 0.007
  294. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005 Dec; 68(6):2801-8.
    View in: PubMed
    Score: 0.007
  295. Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. J Am Soc Nephrol. 2005 Dec; 16(12):3711-20.
    View in: PubMed
    Score: 0.007
  296. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL. Kidney Int. 2005 Aug; 68(2):788-95.
    View in: PubMed
    Score: 0.007
  297. Older emergency department patients with acute myocardial infarction receive lower quality of care than younger patients. Ann Emerg Med. 2005 Jul; 46(1):14-21.
    View in: PubMed
    Score: 0.007
  298. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol. 2005 Jun; 32(6):1076-80.
    View in: PubMed
    Score: 0.007
  299. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005 Mar; 67(3):1047-52.
    View in: PubMed
    Score: 0.007
  300. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 Nov 16; 141(10):745-52.
    View in: PubMed
    Score: 0.006
  301. Gender and risk of adverse outcomes in heart failure. Am J Cardiol. 2004 Nov 01; 94(9):1147-52.
    View in: PubMed
    Score: 0.006
  302. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):429S-456S.
    View in: PubMed
    Score: 0.006
  303. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt). 2004 May; 13(4):381-9; discussion 390-2.
    View in: PubMed
    Score: 0.006
  304. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003 Sep 22; 163(17):2052-7.
    View in: PubMed
    Score: 0.006
  305. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003 Sep 11; 349(11):1019-26.
    View in: PubMed
    Score: 0.006
  306. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S148-53.
    View in: PubMed
    Score: 0.006
  307. Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack. Arch Neurol. 2002 Sep; 59(9):1437-41.
    View in: PubMed
    Score: 0.005
  308. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation. 2001 Nov 06; 104(19):2300-4.
    View in: PubMed
    Score: 0.005
  309. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol. 2001 Nov 01; 38(5):1297-301.
    View in: PubMed
    Score: 0.005
  310. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001 Sep 18; 135(6):393-400.
    View in: PubMed
    Score: 0.005
  311. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail. 2001 Sep; 7(3):221-8.
    View in: PubMed
    Score: 0.005
  312. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001 Aug; 38(2):478-85.
    View in: PubMed
    Score: 0.005
  313. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001 Jun 05; 103(22):2668-73.
    View in: PubMed
    Score: 0.005
  314. Overuse of administrative data to measure underuse of care. JAMA. 2001 Feb 14; 285(6):735; discussion 736-7.
    View in: PubMed
    Score: 0.005
  315. Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. J Am Coll Cardiol. 2000 Sep; 36(3):706-12.
    View in: PubMed
    Score: 0.005
  316. Outcome following acute myocardial infarction: are differences among physician specialties the result of quality of care or case mix? Arch Intern Med. 1999 Jul 12; 159(13):1429-36.
    View in: PubMed
    Score: 0.004

© 2026 Kaiser Permanente

Your Privacy Choices